Tanakan


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 26.1%
Hypertension 10.7%
Product Used For Unknown Indication 9.9%
Ill-defined Disorder 8.8%
Dementia Alzheimer's Type 6.6%
Insomnia 4.1%
Type 2 Diabetes Mellitus 3.6%
Benign Prostatic Hyperplasia 3.3%
Gastrointestinal Disorder 3.3%
Dizziness 2.7%
Epilepsy 2.7%
Thrombosis Prophylaxis 2.5%
Anxiety 2.2%
Calcium Deficiency 2.2%
Sensation Of Heaviness 2.2%
Vitamin D Deficiency 2.2%
Gout 1.9%
Bronchitis 1.6%
Depression 1.6%
Rhinitis Allergic 1.6%
Renal Failure 13.2%
Pyrexia 11.8%
Haemolytic Anaemia 10.3%
Renal Failure Acute 7.4%
Fall 5.9%
Pulmonary Fibrosis 5.9%
Tonsillitis 5.9%
Temperature Intolerance 4.4%
Tricuspid Valve Disease 4.4%
Bone Marrow Failure 2.9%
Condition Aggravated 2.9%
Hyperkalaemia 2.9%
Hyponatraemia 2.9%
Lactic Acidosis 2.9%
Muscle Haemorrhage 2.9%
Pruritus 2.9%
Sudden Death 2.9%
Transaminases Increased 2.9%
Vomiting 2.9%
Accidental Overdose 1.5%
Concomitant
Drug Use For Unknown Indication 27.7%
Product Used For Unknown Indication 19.7%
Hypertension 11.6%
Pain 4.3%
Bronchopneumopathy 4.1%
Atrial Fibrillation 4.0%
Osteoporosis 3.5%
Prophylaxis 3.5%
Dementia Alzheimer's Type 2.1%
Bronchopulmonary Aspergillosis 2.0%
Depression 2.0%
Diabetes Mellitus 2.0%
Neuralgia 1.9%
Anxiety 1.7%
Bronchitis 1.7%
Constipation 1.7%
Type 2 Diabetes Mellitus 1.7%
Parkinson's Disease 1.6%
Vitamin Supplementation 1.6%
Epilepsy 1.5%
Vomiting 11.1%
Hyponatraemia 7.4%
Weight Increased 7.4%
Vertigo 6.2%
Weight Decreased 6.2%
Bone Marrow Failure 5.6%
Fall 5.6%
Malaise 4.9%
Pulmonary Embolism 4.9%
Renal Failure 4.9%
Pyrexia 4.3%
White Blood Cell Count Increased 4.3%
Pancytopenia 3.7%
Renal Failure Acute 3.7%
Thrombocytopenia 3.7%
Urinary Tract Infection 3.7%
Cytolytic Hepatitis 3.1%
Oedema Peripheral 3.1%
Syncope 3.1%
Vision Blurred 3.1%

Drug Data